the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
Last Updated on October 1, 2016 by Joseph Gut – thasso September 30, 2016 – This is very good news for patients suffering from any form of a rare disease. The European Medicines Agency (EMA) and the American Food and Drug …
Rare diseases: EU and US collaborate to boost development of therapies Read more »
Last Updated on September 26, 2016 by Joseph Gut – thasso September 26, 2016 – Toxic epidermal necrolysis (TEN), also known as Lyell’s syndrome, is a rare, life-threatening skin condition that is usually caused by a reaction to drugs. The disease causes the top layer of …
Last Updated on September 21, 2016 by Joseph Gut – thasso September 22, 2016 – The pharmacologically active compound known as sildenafil is largely used to treat erectile dysfunction (on the market for this indication under the trade name Viagra) and pulmonary arterial hypertension (on …
Last Updated on September 20, 2016 by Joseph Gut – thasso September 19, 2016 – This post presents below a virtually unedited announcement by the American Food & Drug Administration (FDA) concerning Duchenne Muscular Dystrophy (DMD) therapy option which gives much …
Eteplirsen (Exondys 51) for Duchenne Muscular Dystrophy (DMD) approved Read more »
Last Updated on September 18, 2016 by Joseph Gut – thasso September 17, 2016 – Breast cancer is the most common cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012. In Europe, there were an estimated 464,000 …
Palbociclib (Ibrance): New treatment for advanced or metastatic breast cancer in the EU Read more »
Last Updated on September 9, 2016 by Joseph Gut – thasso September 09. 2016 – The pre-clinical animal model and Phase 1b placebo-controlled study in prodromal and mild Alzheimer Disease (AD) patients (n=165), both demonstrate that aducanumab reduced amyloid-beta in …
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease Read more »
Last Updated on September 8, 2016 by Joseph Gut – thasso September 08, 2016 – Ovarian cancer occurs when abnormal cells in or near the ovaries grow and form a malignant (cancerous) tumor. In the United States, ovarian cancer is the …
FDA recommends against use of ovarian cancer screening tests Read more »
Last Updated on September 7, 2016 by Joseph Gut – thasso September 06, 2016 – Apple has updated it’s App Store guidelines on health and medical Apps. Developers of health and medical apps will now have strict rules to abide by …
Apple App Store guidelines tightened for health and medical apps Read more »
Last Updated on September 6, 2016 by Joseph Gut – thasso September 06, 2016 – Genetic mutations associated with acquired resistance to PD-1 blockade in melanoma have been suspected to be involved in the clinical observation that while approximately 75% of …
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma Read more »
Last Updated on September 4, 2016 by Joseph Gut – thasso September 04, 2016 – Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene …